Cargando…

An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer

BACKGROUND: Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach for resectable PLC (rPLC) remains controversial. Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yizhen, Yang, Zhenyun, Hu, Zili, Yang, Zhoutian, Chen, Jinbin, Wang, Juncheng, Zhou, Zhongguo, Xu, Li, Chen, Minshan, Zhang, Yaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972775/
https://www.ncbi.nlm.nih.gov/pubmed/36849920
http://dx.doi.org/10.1186/s12885-023-10630-x
_version_ 1784898388524793856
author Fu, Yizhen
Yang, Zhenyun
Hu, Zili
Yang, Zhoutian
Chen, Jinbin
Wang, Juncheng
Zhou, Zhongguo
Xu, Li
Chen, Minshan
Zhang, Yaojun
author_facet Fu, Yizhen
Yang, Zhenyun
Hu, Zili
Yang, Zhoutian
Chen, Jinbin
Wang, Juncheng
Zhou, Zhongguo
Xu, Li
Chen, Minshan
Zhang, Yaojun
author_sort Fu, Yizhen
collection PubMed
description BACKGROUND: Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach for resectable PLC (rPLC) remains controversial. Herein, we aimed to develop a nomogram to determine the most appropriate resection approach for the individual patient. METHODS: Patients with rPLC who underwent hepatectomy from January 2013 to December 2018 were reviewed. Prediction model for risky surgery during LLR was constructed. RESULTS: A total of 900 patients in the LLR cohort and 423 patients in the OLR cohort were included. A history of previous antitumor treatment, tumor diameter, tumor location and resection extent were independently associated with risky surgery of LLR. The nomogram which was constructed based on these risk factors demonstrated good accuracy in predicting risky surgery with a C index of 0.83 in the development cohort and of 0.76 in the validation cohort. Patients were stratified into high-, medium- or low-risk levels for receiving LLR if the calculated score was more than 0.8, between 0.2 and 0.8 or less than 0.2, respectively. High-risk patients who underwent LLR had more blood loss (441 ml to 417 ml) and a longer surgery time (183 min to 150 min) than those who received OLR. CONCLUSIONS: Patients classified into the high-risk level for LLR instead undergo OLR to reduce surgical risks and complications and patients classified into the low-risk level undergo LLR to maximize the advantages of minimally invasive surgery. TRIAL REGISTRATION: This study was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2100049446). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10630-x.
format Online
Article
Text
id pubmed-9972775
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99727752023-03-01 An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer Fu, Yizhen Yang, Zhenyun Hu, Zili Yang, Zhoutian Chen, Jinbin Wang, Juncheng Zhou, Zhongguo Xu, Li Chen, Minshan Zhang, Yaojun BMC Cancer Research BACKGROUND: Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach for resectable PLC (rPLC) remains controversial. Herein, we aimed to develop a nomogram to determine the most appropriate resection approach for the individual patient. METHODS: Patients with rPLC who underwent hepatectomy from January 2013 to December 2018 were reviewed. Prediction model for risky surgery during LLR was constructed. RESULTS: A total of 900 patients in the LLR cohort and 423 patients in the OLR cohort were included. A history of previous antitumor treatment, tumor diameter, tumor location and resection extent were independently associated with risky surgery of LLR. The nomogram which was constructed based on these risk factors demonstrated good accuracy in predicting risky surgery with a C index of 0.83 in the development cohort and of 0.76 in the validation cohort. Patients were stratified into high-, medium- or low-risk levels for receiving LLR if the calculated score was more than 0.8, between 0.2 and 0.8 or less than 0.2, respectively. High-risk patients who underwent LLR had more blood loss (441 ml to 417 ml) and a longer surgery time (183 min to 150 min) than those who received OLR. CONCLUSIONS: Patients classified into the high-risk level for LLR instead undergo OLR to reduce surgical risks and complications and patients classified into the low-risk level undergo LLR to maximize the advantages of minimally invasive surgery. TRIAL REGISTRATION: This study was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2100049446). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10630-x. BioMed Central 2023-02-27 /pmc/articles/PMC9972775/ /pubmed/36849920 http://dx.doi.org/10.1186/s12885-023-10630-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fu, Yizhen
Yang, Zhenyun
Hu, Zili
Yang, Zhoutian
Chen, Jinbin
Wang, Juncheng
Zhou, Zhongguo
Xu, Li
Chen, Minshan
Zhang, Yaojun
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
title An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
title_full An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
title_fullStr An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
title_full_unstemmed An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
title_short An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
title_sort integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972775/
https://www.ncbi.nlm.nih.gov/pubmed/36849920
http://dx.doi.org/10.1186/s12885-023-10630-x
work_keys_str_mv AT fuyizhen anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT yangzhenyun anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT huzili anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT yangzhoutian anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT chenjinbin anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT wangjuncheng anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT zhouzhongguo anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT xuli anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT chenminshan anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT zhangyaojun anintegratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT fuyizhen integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT yangzhenyun integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT huzili integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT yangzhoutian integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT chenjinbin integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT wangjuncheng integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT zhouzhongguo integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT xuli integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT chenminshan integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer
AT zhangyaojun integratedstrategyfordecidingopenversuslaparoscopichepatectomyforresectableprimarylivercancer